Thursday, 21 July 2016

An Atlas of Surgical Anatomy

                                                           




                                                                   Click Here

Dear Doctor,

You can download and use thesebooks for your personal use as such without any modification. But please give the authors the credit they deserve and do not change the author’s name.



An appeal :If any of you have these type of books or links in your collection please mail to us : mijjumaniyar@gmail.com

A guide to laparoscopic Surgery

                                             


                                                         Click Here


Dear Doctor,

You can download and use thesebooks for your personal use as such without any modification. But please give the authors the credit they deserve and do not change the author’s name.


An appeal :If any of you have these type of books or links in your collection please mail to us : mijjumaniyar@gmail.com

Bailey and loves short practice of Surgery 25 ed

                                               

                                                           Click Here

Dear Doctor,

You can download and use thesebooks for your personal use as such without any modification. But please give the authors the credit they deserve and do not change the author’s name.


An appeal :If any of you have these type of books or links in your collection please mail to us : mijjumaniyar@gmail.com

Williams Obstetrics 23rd Edition

Price One Share


                                                      




                                                               Click Here


Dear Doctor,

You can download and use thesebooks for your personal use as such without any modification. But please give the authors the credit they deserve and do not change the author’s name.


An appeal :If any of you have these type of books or links in your collection please mail to us : mijjumaniyar@gmail.com

Manual of Laboratory & Diagnostic Tests McGraq -Hill's

                                     



                                                                       Click Here

Gynaecology Illustrated

                                      


 
                                                        Click Here

Obesity in the Asia-Pacific Region

                      Obesity in the Asia-Pacific Region


With much of the focus resting on under-nutrition and micronutrients defi ciency, it is easy to dismiss obesity as nothing but a disease peculiar to affl uent nations. However, experts warned that obesity is reaching an epidemic proportion, and should thus be treated as a valid health concern.

Consider these statistics: in 2005, 1.6 billion adults over the age of 15 are overweight and at least 400 million of this number is obese. By 2015, the World Health Organization calculates the number of overweight adults to increase to 2.3 billion, with 700 million of them clinically obese. Each year at least 2.6 million people die from health complications resulting from all the excessive weight.

A rising health concern

Before its current alarming rate, excessive weight gain is a problem apparent only in high-income countries. Eventually, developing countries partake in the global shift in diet towards an increased intake of energy-dense foods that are high in fat and sugars but low in vitamins, minerals and other micronutrients. This is coupled with decreased physical activity due to increasing urbanization, wherein once rural communities enjoy the comforts of modern technology in their work and transportation.

In the Asia-Pacifi c region, people shifted from traditional food staples toward Westernized, high-fat food. Local consumption of vegetables, fruits and root crops decreased while that of mutton fl aps, turkey tails, vegetable oils and fried foods rose, as well as high intakes of alcohol, soft drinks and confectionery. Dietary surveys imply that in some islands over half of all food energy comes from fat. Not surprisingly, imported foods comprise between 30 and 90 percent of all foodstuffs eaten in the Pacific.

With the Pacifi c Islanders’ unhealthy diet comes a decline in their physical activities. Manual farming and fi shing laborers plummeted in number while reliance on motors for travel grew. Urban crowding, unemployment and family breakdown increased violence and crime, discouraging activity in certain areas or at particular times because of safety hazards.

For these reasons, some of the highest levels of adult obesity in the world are found in the Pacifi c Islands, higher than those found in the USA. Obesity rates range from around two percent of the adult population in highland Papua New Guinea to nearly 80 percent in Nauru. In most communities the rate of obesity is above 20 percent, exceeding the level in more developed countries such as Australia.

There are conflicting views regarding obesity as an imminent health problem. In a culture where being “big” is seen as a symbol of health, well-being, status and beauty, excessive fat is not associated with diseases or even death. In the past, being overweight may have saved people during phases of starvation and infectious diseases. Today, it merely contributes to the most common illnesses of diabetes and heart disease.

Health complications

Coronary heart disease and stroke are the main causes of early adult death in the region, both being possible health complications of obesity. In comparison, the rates of type 2 diabetes in many Pacifi c communities are higher than those in European countries. Other health risks that may result from obesity include musculoskeletal disorders, some cancers (endometrial, breast, and colon), hypertension, dyslipidaemia, ischaemic stroke, sleep apnoea, degenerative joint disease (such as arthritis), gallstones and problems in fertility.

More than being a sickness of the “elite”, extreme largeness is no longer confi ned to just a few people. A World Bank analysis reports that management of noncommunicable diseases such as diabetes, heart disease and hypertension accounts for around half of all health care expenses in certain Pacifi c countries. When the workforce becomes ill due to obesity-related injury and illness, fi nancial burdens imposes itself on the community.

Double jeopardy

Obesity often coexists with undernutrition in the Pacific. Globally, at least 20 million children under the age of 5 years are overweight. Within the Pacific region, 2 to 23 percent of children under 5 years old may have mild to moderate undernutrition while 2 to 30 percent of children could be considered overweight or obese. Insufficient pre-natal, infant and young child nutrition followed by exposure to high-fat, energy-dense, micronutrient poor foods and lack of physical activity connects the line from undernutrition to obesity—both visible effects of malnutrition. As a result of inadequate nutrition in pregnancy and childhood, the development of severe forms of non-communicable disease may appear early in adulthood. Low- and middle-income countries are the ones severely affected by these conditions, dealing with the problems of infectious disease and undernutrition while simultaneously experiencing chronic disease risk factors such as obesity and overweight. And like an evil paradox, it is not rare to fi nd undernutrition and obesity existing side-by-side within the same country, community or even within the same household.

Obviously, there is a need to strike a balance between energy expenditure and healthy weight. Programs such as the WHO Global Strategy on Diet, Physical Activity and Health aim to deliver these changes. Adopted by the World Health Assembly in 2004, it describes the actions needed to support the adoption of nutritional diets and regular physical activity. These include limiting energy intake from total fats and shifting fat consumption away from saturated fats to unsaturated fats while increasing consumption of fruit and vegetables, as well as legumes, whole grains and nuts. Increasing physical activity is also vital, even more if weight control is necessary.

More importantly, creating awareness in the public mind is essential. These can be executed thru programs that address the social, economic and environmental influences that promote appropriate lifestyle changes and healthy behavior. Improved health care services, disease monitoring and surveillance can also achieve positive results in combating the spread of obesity among Pacific Islanders.

Tuberculosis Why TB Persists

Every five years, the National Statistics Office conducts a National Demographic and Health Survey which mainly looks at the health of women and children. The earliest surveys focused on family planning, but over the years it has expanded to become the most comprehensive source of information on other health issues in the country.

Just to give a few examples, you can find statistics on the use of tobacco, domestic violence and sexual behavior. There is also information on households’ access to safe water, ownership of durable goods, exposure to mass media. What I find most useful in the NDHS is the breakdown of statistics according to urban/rural residence, region, age groups and, in more recent surveys, income.

Except in 2003, all the surveys have been limited to women respondents, but the information remains important because our women play so many important roles in health care, within and outside the home.

The final results from the 2008 survey, with 13, 594 women interviewed from all the regions in the Philippines, were presented last week. The NSO asked me to respond to the findings concerning HIV/AIDS and TB during the dissemination symposium, and I thought I’d share my thoughts about the findings about TB.

TB has been with us since time immemorial, so it is not surprising women’s awareness of the disease was over 98 percent. But even then, I did wonder why awareness was not 100 percent. In the National Capital Region, 0.3 percent of respondents were not aware of TB and in the Autonomous Region in Muslim Mindanao (ARMM), the figure was 8 percent. In absolute numbers, you’re talking of thousands of women who have not heard of TB.

What was even more disturbing were the figures that came out on knowledge about the cause and mode of transmission of the disease. TB is caused by Mycobacterium tuberculosis, which is a bacteria and which is airborne, mainly spread by coughing.

The awareness of this airborne spread was quite low, ranging from 34 percent in the ARMM to 62 percent in the NCR. Even more shocking, when the women were asked if they knew that TB was caused by bacteria, knowledge of this fact ranged from 12 percent in Ilocos to 34 percent in the NCR. Even among college-educated women, knowledge of a microbial cause was about 33 percent.

Terrorists

The NDHS statistics offer us some clues as to why TB remains so widespread in the Philippines, with one of the highest infection rates in the world. TB is also still the fourth leading cause of death in the country, with about 100 Filipinos dying each day from this plague.

As a medical anthropologist, I would want to have a deeper investigation of people’s perceptions of the disease. I wonder if Filipinos mainly associate “bacteria” and “germs” more with hygiene (“dumi” or dirtiness) and certain ailments like diarrheas (still because of the “dumi” aspect).

The hordes of durarista (people who spit anywhere, who I consider terrorists) among us shows that people don’t think of this habit as a way of spreading diseases, including TB. In fact, people see spitting as a hygienic measure—time and time again, Filipinos have argued with me that it’s “cleaner” to spit out the offensive phlegm rather than to keep it in the body!

So, if people don’t attribute TB to microbes, how do they explain the disease? The most frequently cited causes were smoking (59 percent) and alcohol drinking (44 percent). Inheritance came in third, in a tie with microbial causes, at 23 percent. Again, what was striking was that even among college educated and upper-income women, there was the same ranking, meaning more women attributed TB to smoking and alcohol drinking rather than microbes.

There is an amazing mix of beliefs around TB. For example, the higher the educational status of women, the higher the percentage of those who believed TB could be spread through sexual contact. Only 0.6 percent of women who had no education believed in sexual transmission of TB, increasing to about 3 percent for those with elementary education, 4 percent for those with high school education and 9 percent for those with college education.

What we’re seeing are misplaced fears, where people don’t recognize the risks of airborne transmission but might fear TB from sex. The NDHS did find, too, that 78 percent of the women thought TB could be transmitted from sharing utensils. This is actually a myth, but many households with a TB patient will still segregate their eating utensils.

TB patients also have to live with stigma. The NDHS found 60 percent of respondents willing to work with someone who had been previously treated for TB. In the ARMM, only 38 percent of respondents were willing. Note that this is for someone who has previously been treated. The stigma might be even worse for those who are being treated for TB.

I am certain the stigma contributes to the spread of TB. The disease’s stigma is not just about its infectiousness but about its association with vices like smoking and alcohol use. The idea that it is inherited also contributes to stigma, with families embarrassed to admit having a relative with the disease because it might reflect badly on the entire family.

Sorcery

A few weeks back I wrote about a 19-year-old girl who was brought to Manila from Samar by her family for a respiratory problem. The family had consulted several doctors but refused to accept the diagnosis, which was TB, insisting that it could not happen to a young girl. They insisted that the girl was a victim of barang, or sorcery. Sadly, she died last month, another casualty of the lack of health literacy in the country.

After I got my full report for the 2008 NDHS, I looked up the findings concerning TB in the 2003 NDHS. There had been little improvement in knowledge levels. The 2003 NDHS included a small sample of men, and their knowledge levels about the disease were even more dismal than those for women. In that 2003 NDHS, 24 percent of women, compared to 17 percent of men, knew that TB is caused by bacteria. And while 52 percent of the women knew TB could be transmitted through the air when coughing, only 46 percent of the men had that knowledge.

International agencies have poured in huge amounts of money for TB prevention, as well as treatment, but the NDHS findings of 2003 and 2008 tell us very little progress is being made in terms of people’s knowledge. Beyond the surveys, we need more research to probe deeply into how people look at TB. Maybe the lack of awareness is due to our reluctance to openly talk about the disease and the doctors’ use of euphemisms like “weak lungs.” And women’s fears of sexual transmission may not be totally irrational since a sexual partner with TB can still transmit the germs, not through the sex itself but through coughing.

TB will continue to thrive in the country if we don’t resolve all these accumulated perceptions and misconceptions. The NDHS reminds us that such ignorance cuts across classes, age groups, educational status, and geographical regions.


By Michael Tan, Pinoy Kasi, 

Text Book of Obstetrics

                                




                                                            Click Here


Dear Doctor,

You can download and use thesebooks for your personal use as such without any modification. But please give the authors the credit they deserve and do not change the author’s name.



An appeal :If any of you have these type of books or links in your collection please mail to us : mijjumaniyar@gmail.com

ECG Made Easy By John R. Hampton

                                             




                                         Click Here


Dear Doctor,

You can download and use thesebooks for your personal use as such without any modification. But please give the authors the credit they deserve and do not change the author’s name.


An appeal :If any of you have these type of books or links in your collection please mail to us : mijjumaniyar@gmail.com

Career in pharmacy

Career in Pharmacy: PHARMA ENTREPRENEURSHIP


Pharmacists are medication experts who use their detailed knowledge of medicines to help patients get well. Duties include dispensing medications, assuring the safety and appropriateness of the prescribed therapy, monitoring patient health and progress, partnering with consumers and patients to provide education and advice on the use of medications. They also collaborate with physicians, nurses, and other health care team members to provide expertise on drug decisions and improve patient outcomes, providing knowledge about the composition of drugs and safeguard drug purity and strength.

The Pharmacy profession is not only a noble profession but also equally technical one and as a result of this Pharmacy graduates has multiple scope unlike most of the other graduates. Entrepreneurship is the final word in any one's career.


Pharmacy professionals can become an entrepreneur by owning a Pharmacy or an Industry or an Institution or owning a R&D lab. The ‘Pharma Entrepreneurship’ can be understood better if we understand the various scopes for pharmacists. Various Scopes for Pharmacist Government - Industry - Research & Development – Marketing - Clinical, Hospital & Community Pharmacist - Consultancy Services - Opportunities Abroad – Entrepreneur. 


The professionals can enter in to Manufacturing or Quality control or Quality assurance or Regulatory affairs. For entering in to Research and development a person should have clear vision during early stage of his education. Based on his interest he can select the field of Research like Formulation Analytical etc. India is surging to become the hub for contract Research and Product Development. Marketing is very attractive for young pharmacy candidates. They can go in to pharmaceutical selling and can grow faster in their career. The retail business of drugs in India is growing by 12% to 14% every year. To own a pharmacy will also be a very good option for the pharmacy graduates. The best option to become an entrepreneur is to acquire sufficient skills in whatever field a pharmacist is deciding to work with.




Pharmacists are experts on drug administration, therapy and safety profile. They are the integral part of the national health care industry that plays a pivotal role providing appropriate health care management and monitors the progress. Pharmacists optimise the use of medications for the benefit of public.

Doctor of Pharmacy

Pharm.D (Doctor of Pharmacy)

Pharm.D., Doctor of Pharmacy, Syllabus, Eligibility, Duration, Degree Course, Jobs

Syllabus Book Download Click Here..

Pharm.D.
Doctor of Pharmacy
Duration: 6 Years
Level: Doctorate
Type: Degree
Eligibility:10+2



Pharm.D. is a Professional Pharmacy Doctoral Programme. 'Pharm.D.' is a Latin term which stands for 'Pharmaciae Doctor' which means 'Doctor of Pharmacy'. Pharmacy is the art and science of preparing and dispensing drugs and medicines. The course is also known as Pharma.D., which many of the medical institutesprefer to term it as such. Pharm.D. is a registrable qualification under the Pharmacy Act 1948. Pharmacy Council of India (PCI) is the regulatory body of Pharmacy education in India. Pharmacy Council of India introduced the 6 years Pharm.D. course in India from the academic year 2008. Pharm.D. enables one to practice the profession of a Pharmacist under the Pharmacy Act, 1948. Doctor of Pharmacy Programs is focused on class room theory, penetrative laboratory experiments and motivated research projects. Only PCI approved Colleges can offer Pharm.D. course. There are only a limited number of Pharmacy Schools which provide Doctor of Pharmacy degree.


Pharm.D is started in 2008 with only a few colleges for the first batch. But over years the colleges offering this course have increased to a good number. By the time the First Regular(6 yrs) batch was graduated in 2014 the total number of colleges were approximately, which were ready to take in the admissions for first year. By seeing the present trend it is expected to rise even more in the coming future.
Number of students showing interest towards the clinical pharmacy profession has are been significantly growing. Since PCI gives approval to run this course only for its Approved institutions already running B.pharm with passed out batches, Quality could be maintained up to a certain extent.
While the number of colleges have been gradually increased year after year in south india, there are not many approvals for Pharm.D in north india, with only a couple of colleges in Punjab and U.P, students from this region are migrating to south india to pursue this course.
There are 2 types of Pharm.D.
Regulations for the both Courses as per PCI 2008-
1. Pharm.D. - The duration of the course shall be 6 academic years (5 years of study and 1 year of internship or residency) full time with each academic year spread over a period of not less than two hundred working days.
The period of 6 years duration is divided into two phases –
Phase I – consisting of First, Second, Third, Fourth and Fifth academic year.
Phase II – consisting of internship or residency training during sixth year involving posting in speciality units. It is a phase of training wherein a student is exposed to actual pharmacy practice or clinical pharmacy services and acquires skill under supervision so that he or she may become capable of functioning independently.
2. Pharm.D. (Post Baccalaureate) - The duration of the course shall be for 3 academic years (2 years of study and 1 year internship or residency) full time with each academic year spread over a period of not less than two hundred working days.
The period of 3 years duration is divided into two phases –
Phase I – consisting of First and Second academic year.
Phase II – consisting of Internship or residency training during third year involving posting in speciality units. It is a phase of training wherein a student is exposed to actual pharmacy practice or clinical pharmacy services, and acquires skill under supervision so that he or she may become capable of functioning independently.
The number of admissions for the Pharm.D. program are prescribed by the Pharmacy Council of India from time to time and is restricted to 30 students intake for Pharm.D. & 10 students for Pharm.D. (PB) per academic year as per 2008 regulations.
Pharm.D. Eligibility:

For Pharm.D. (6 year course):

A pass in any of the following examinations -

  • 10+2 examination with Physics and Chemistry as compulsory subjects along with one of the following subjects: Mathematics or Biology.
  • A pass in D.Pharm. course from an institution approved by the Pharmacy Council of India under section 12 of the Pharmacy Act.
  • Any other qualification approved by the Pharmacy Council of India as equivalent to any of the above examinations.
  • Provided that a student should complete the age of 17 years on or before 31st December of the year of admission to the course.
  • Provided that there shall be reservation of seats for the students belonging to the Scheduled Castes, Scheduled Tribes and other Backward Classes in accordance with the instructions issued by the Central Government/State Government/Union Territory Administration as the case may be from time to time.

For Pharm.D. (Post Baccalaureate):
  • A pass in B.Pharm. from an institution approved by the Pharmacy Council of India under section 12 of the Pharmacy Act.
  • Provided that there shall be reservation of seats for the students belonging to the Scheduled Castes, Scheduled Tribes and other Backward Classes in accordance with the instructions issued by the Central Government/State Government/Union Territory Administration as the case may be from time to time.
Doctor of Pharmacy Subjects:

The following subjects are of Pharm.D. (6 year course). Pharm.D. (Post Baccalaureate) subjects may vary from the former.
  1. Pharmaceutics
  2. Medicinal Biochemistry
  3. Pharmaceutical Microbiology
  4. Pharmacognosy & Phytopharmaceuticals
  5. Pharmaceutical Analysis
  6. Clinical Research

YEAR I
S. No
                              SUBJECTS OF STUDY
1.1
 Human Anatomy and Physiology
1.2
Pharmaceutics
1.3
Medicinal Biochemistry
1.4
Pharmaceutical Organic Chemistry
1.5
Pharmaceutical Inorganic Chemistry
1.6
Remedial Mathematics/ Biology
YEAR II
2.1
Pathophysiology
2.2
Pharmaceutical Microbiology 
2.3
Pharmacognosy & Phytopharmaceuticals
2.4
Pharmacology I
2.5
Community Pharmacy
2.6
Pharmacotherapeutics-I
YEAR III
3.1
Pharmacology II
3.2
Pharmaceutical Analysis
3.3
Pharmacotherapeutics II
3.4
Pharmaceutical Jurisprudence
3.5
Medicinal Chemistry
3.6
Pharmaceutical Formulations
YEAR IV
4.1
Pharmacotherapeutics III
4.2
Hospital Pharmacy
4.3
Clinical Pharmacy
4.4
Biostatistics & Research Methodology
4.5
Biopharmaceutics & Pharmacokinetics
4.6
Clinical Toxicology
YEAR V
5.1
Clinical Research
5.2
Pharmacoepidemiology & Pharmacoeconomics
5.3
Clinical Pharmacokinetics & Pharmacotherapeutic Drug Monitoring
5.4
Clerkship
5.5
Project work (Six Months)
5.6
Clinical Research
YEAR VI
6.1
Internship or residency training includes postings in specialty units. Student should independently provide the clinical pharmacy services to the allotted wards.
(i) 6 months in General Medicine department.
(ii) 2 months each in three other specialty departments.

Examination:

(1) Every year there shall be an examination to examine the students.
(2) Each examination may be held twice every year. The first examination in a year shall be the annual examination and the second examination shall be supplementary examination.
(3) The examinations shall be of written and practical (including oral nature) carrying maximum marks for each part of a subject as indicated in Tables above:

Eligibility for appearing Examination:

Only such students who produce certificate from the Head of the Institution in which he or she has undergone the Pharm.D. or as the case may be, the Pharm.D. (Post Baccalaureate) course, in proof of his or her having regularly and satisfactorily undergone the course of study by attending not less than 80% of the classes held both in theory and in practical separately in each subject shall be eligible for appearing at examination.

Mode of Examinations:

  • Theory examination shall be of 3 Hours and Practical Examination shall be of 4 Hours duration.
  • A Student who fails in theory or practical examination of a subject shall re-appear both in theory and practical of the same subject.
  • Practical examination shall also consist of a viva –voce (Oral) examination.
  • Clerkship examination – Oral examination shall be conducted after the completion of clerkship of students. An external and an internal examiner will evaluate the student. Students may be asked to present the allotted medical cases followed by discussion.
  • Students’ capabilities in delivering clinical pharmacy services, pharmaceutical care planning and knowledge of therapeutics shall be assessed.
  • A regular record of both theory and practical class work and examinations conducted in an institution imparting training for Pharm.D. or as the case may be, Pharm.D. (Post Baccalaureate) course, shall be maintained for each student in the institution and 30 marks for each theory and 30 marks for each practical subject shall be allotted as sessional.
  • There shall be at least two periodic sessional examinations during each academic year and the highest aggregate of any two performances shall form the basis of calculating sessional marks.
  • A student shall not be declared to have passed examination unless he or she secures at least 50% marks in each of the subjects separately in the theory examinations, including sessional marks and at least 50% marks in each of the practical examinations including sessional marks.
  • The students securing 60% marks or above in aggregate in all subjects in a single attempt at the Pharm.D. or as the case may be, Pharm. D. (Post Baccalaureate) course examination shall be declared to have passed in first class.
  • Students securing 75% marks or above in any subject or subjects shall be declared to have passed with distinction in the subject or those subjects provided he or she passes in all the subjects in a single attempt.
Eligibility for Promotion to Next Year:
  • All students who have appeared for all the subjects and passed the first year annual examination are eligible for promotion to the second year and, so on.
  • However, failure in more than two subjects shall debar him or her from promotion to the next year classes.
Internship:
  • Internship is a phase of training wherein a student is expected to conduct actual practice of pharmacy and health care and acquires skills under the supervision so that he or she may become capable of functioning independently.
  • Every student has to undergo one year internship.
Certificate of Passing Examination:

Every student who has passed the examinations for the Pharm.D. (Doctor of Pharmacy) or Pharm.D. (Post Baccalaureate) (Doctor of Pharmacy) as the case may be, shall be granted a certificate by the examining authority.


Practical Training:


Hospital Posting:
  • Every student shall be posted in constituent hospital for a period of not less than fifty hours to be covered in not less than 200 working days in each of second, third & fourth year course.
  • Each student shall submit report duly certified by the preceptor and duly attested by the Head of the Department or Institution as prescribed. In the fifth year, every student shall spend half a day in the morning hours attending ward rounds on daily basis as a part of clerkship. Theory teaching may be scheduled in the afternoon.
Project Work:
  • To allow the student to develop data collection and reporting skills in the area of community, hospital and clinical pharmacy, a project work shall be carried out under the supervision of a teacher.
  • The project topic must be approved by the Head of the Department or Head of the Institution. The same shall be announced to students within one month of commencement of the fifth year classes.
  • Project work shall be presented in a written report and as a seminar at the end of the year. External and the internal examiners shall do the assessment of the project work.
  • Project work shall comprise of objectives of the work, methodology, results, discussions and conclusions.
Objectives of project work:

The main objectives of the project work is to-

(i) show the evidence of having made accurate description of published work of others and of having recorded the findings in an impartial manner.

(ii) Develop the students in data collection, analysis and reporting and interpretation skills.

Methodology:

To complete the project work following methodology shall be adopted, namely:
  • Students shall work in groups of not less than two and not more than four under an authorised teacher.
  • Project topic shall be approved by the Head of the Department or Head of the Institution.
  • Project work chosen shall be related to the pharmacy practice in community, hospital and clinical setup. It shall be patient and treatment (Medicine) oriented, like drug utilisation reviews, pharmacoepidemiology, pharmacovigilance or pharmacoeconomics.
  • Project work shall be approved by the institutional ethics committee.
  • Student shall present at least three seminars, one in the beginning, one at middle and one at the end of the project work.
  • Two-page write-up of the project indicating title, objectives, methodology anticipated benefits and references shall be submitted to the Head of the Department or Head of the Institution.
Reporting:
  • Student working on the project shall submit jointly to the Head of the Department or Head of the Institution a project report of about 40-50 pages. Project report should include a certificate issued by the authorised teacher, Head of the Department as well as by the Head of the Institution.
  • Project report shall be computer typed in double space using Times Roman font on A4 paper. The title shall be in bold with font size 18, sub-tiles in bold with font size 14 and the text with font size 12. The cover page of the project report shall contain details about the name of the student and the name of the authorised teacher with font size 14.
  • Submission of the project report shall be done at least one month prior to the commencement of annual or supplementary examination.
Evaluation:

The following methodology shall be adopted for evaluating the project work...


(i) Project work shall be evaluated by internal and external examiners.

(ii) Students shall be evaluated in groups for four hours (i.e., about half an hour for a group of four students).


(iii) Three seminars presented by students shall be evaluated for twenty marks each and the average of best two shall be forwarded to the university with marks of other subjects.



Award of Sessional Marks and Maintenance of Records:

The sessional marks in practicals shall be allotted on the following basis:-

          (i) Actual performance in the sessional examination (20 marks);

      (ii) Day to day assessment in the practical class work, promptness, viva-voce record maintenance, etc. (10 marks).

Minimum Marks for Passing Examination:


Doctor of Pharmacy Course Suitability:

Doctor of Pharmacy Degree is meant for those who want to understand the concepts of clinical research and acquire an in-depth understanding of Pharmacy Practice concepts.

Doctor of Pharmacy Employment Areas
  • Health Centres
  • Academic
  • Drug Control Administration
  • Food and Drug Administration
  • University
  • Foundation/Trust
  • Franchise
  • Hospitals
  • Non-Profit Organization
  • Pharmaceutical Firms
  • Medical Dispensing Store
  • Research Agencies

Doctor of Pharmacy Jobs:

Pharmacy has become an independent branch of science dealing with all aspects of drugs and pharmaceuticals therefore its importance is significant. A Doctor of Pharmacy degree provides enormous national and international career and employment opportunities in areas such as: Academics - Teaching, Research and Development, Administration, Management, etc. and Regulatory Affairs - In Government and Statutory bodies in drug / manufacturing regulation/implementation/Quality Control, etc.


Job Types:

  • Clinical Pharmacist
  • Researcher
  • Drug Inspector
  • Analytical Chemist
  • Retail Pharmacist
  • Dru